A novel nickel-free, low-profile TAVI valve shows promise in treating severe aortic stenosis, according to first-in-human ...

Ultrafast ultrasound shear wave elastography may offer a feasible and non-invasive method to detect the stiffening of heart ...

In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing ...

The Optimum TAVI system has been named “Top Aortic Valve Implantation System 2026” by the publication MED TECH Outlook. A detailed interview of Dr. Thubrikar, author of the 1991 textbook “The Aortic ...

NEW YORK, NY—A systematic program designed to close the diagnosis and treatment gaps for patients with aortic stenosis (AS) ...

Edwards TAVR data has a strong showing at NY Valves 2026 amid intense industry competition from Abbott Laboratories and Medtronic.

BACKGROUND: Undertreatment and delayed treatment of aortic stenosis (AS) are common, both of which are associated with increased mortality. Historically, assessment of quality for AS care has focused ...

Results of care registry released with new TAVR national coverage determination on the hor ...

The superalloy molybdenum-rhenium (MoRe) is a big part of why Boston Scientific is betting big on the MiRus Siegel TAVR heart ...

Kaspar Hallsten, CIO and Portfolio Manager at Rhenman & Partners, built his analytical foundation at PricewaterhouseCoopers ...

It was increasingly clear that clinical trials alone won't tell the full story of how transcatheter aortic valve replacement (TAVR) performs in the real world, according to midterm studies presented ...

CMS’s proposed expansion of Medicare TAVR coverage to include select asymptomatic severe aortic stenosis patients and reduce ...